Genetic Landscape of Rett Syndrome Spectrum: Improvements and Challenges

Int J Mol Sci. 2019 Aug 12;20(16):3925. doi: 10.3390/ijms20163925.

Abstract

Rett syndrome (RTT) is an early-onset neurodevelopmental disorder that primarily affects females, resulting in severe cognitive and physical disabilities, and is one of the most prevalent causes of intellectual disability in females. More than fifty years after the first publication on Rett syndrome, and almost two decades since the first report linking RTT to the MECP2 gene, the research community's effort is focused on obtaining a better understanding of the genetics and the complex biology of RTT and Rett-like phenotypes without MECP2 mutations. Herein, we review the current molecular genetic studies, which investigate the genetic causes of RTT or Rett-like phenotypes which overlap with other genetic disorders and document the swift evolution of the techniques and methodologies employed. This review also underlines the clinical and genetic heterogeneity of the Rett syndrome spectrum and provides an overview of the RTT-related genes described to date, many of which are involved in epigenetic gene regulation, neurotransmitter action or RNA transcription/translation. Finally, it discusses the importance of including both phenotypic and genetic diagnosis to provide proper genetic counselling from a patient's perspective and the appropriate treatment.

Keywords: NGS; Rett syndrome; Rett-like; genetics.

Publication types

  • Review

MeSH terms

  • Animals
  • Gene Expression Regulation
  • Genetic Heterogeneity
  • Humans
  • Methyl-CpG-Binding Protein 2 / genetics
  • Methyl-CpG-Binding Protein 2 / metabolism
  • Mutation
  • Rett Syndrome / diagnosis
  • Rett Syndrome / genetics*
  • Rett Syndrome / metabolism
  • Signal Transduction

Substances

  • MECP2 protein, human
  • Methyl-CpG-Binding Protein 2